fda bpc 157 warning illegal peptide FDA's Overreach on Compounded Peptides Everything You Need to Know
Description
CPT 96372 covers single or multiple intramuscular or subcutaneous injections, while other codes are used for IV push or continuous infusions
Injections deliver B12 directly into the muscle, bypassing the gut
Injectable protocols reach 10 to 20x the tissue concentration of topical application
Risks of Incorrect Reconstitution and When to Seek Advice Incorrect reconstitution of an unlicensed injectable peptide risks overdose, microbial contamination, chemical degradation, and injection site complications
